Sign in / Join Now
ETFs & Funds
Did anyone catch that
is getting an additional $12.5 at end of 2012 on top of the $45 million they already got from Merck? Huh??
is also looking at another $22.5 million in Milestones unrelated to TH-302. Hmmm.. what is going on here. All this additional money??
Merck is also paying 70% of developments costs, which this last quarter gave
$1.1 million back, sweeeeet! Lots of extra treats for
Add a reply...
Latest StockTalks »
people get THLD breaking news and analysis by email alert.
Get email alerts on THLD »
Threshold Pharmaceuticals, Inc.
Get latest price
From other sites
Threshold Pharmaceuticals And National Cancer Institute To Collaborate On Drug Candidate TH-3424
at TheStreet (Dec 19, 2016)
Threshold Pharmaceuticals Announces Presentation And Webcast At The Stifel Healthcare Conference 2016
at TheStreet (Nov 15, 2016)
Threshold Pharmaceuticals Reports Third Quarter Financial Results
at TheStreet (Nov 7, 2016)
Caris Life Sciences And Threshold Pharmaceuticals Collaborate To Utilize Caris' ADAPT Biotargeting System In The Development Program For Evofosfamide
at TheStreet (Oct 25, 2016)
Is Threshold Pharmaceuticals a Buy? (THLD)
at Investopedia (Oct 3, 2016)